Hearn Jay Cho, MD, PhD
img_Hearn Jay Cho
CLINICAL PROFESSOR | Medicine, Hematology and Medical Oncology
CLINICAL PROFESSOR | Immunology & Immunotherapy
Are you a patient?
Specialties
Hematology-Oncology, Cancer (Oncology)
Multi-Disciplinary Training Area
Disease Mechanisms and Therapeutics (DMT)

MD, Weill Medical College of Cornell University

Residency, Internal Medicine, University of California Medical Center San Diego

Fellowship, Hematology & Oncology, New York Presbyterian Hospital-Weill Cornell

Certifications

American Board of Internal Medicine
Publications

Selected Publications

Clonal Hematopoiesis and Inflammation Predict Hematologic Toxicity and Secondary Myeloid Malignancies after B-Cell Maturation Antigen–Directed Chimeric Antigen Receptor T-cell Therapy. Zachary M. Avigan, Jerrel Catlett, Saoirse Bodnar, Darren Pan, Adolfo Aleman, Tianxiang Sheng, Erin Moshier, Adriana C. Rossi, Shambavi Richard, Gurbakhash Kaur, Joshua Richter, Larysa J. Sanchez, Cesar Rodriguez, Hearn Jay Cho, Shafinaz Hussein, Christian Salib, Lewis R. Silverman, Sundar Jagannath, Samir Parekh, Santiago Thibaud. Clinical Cancer Research

Elevated circulating tumor cells reflect high proliferation and genomic complexity in multiple myeloma. Juan Jose Garces, Benjamin Diamond, Tereza Sevcikova, Serafim Nenarokov, Daniel Bilek, Eva Radova, Ondrej Venglar, Veronika Kapustova, Ross Firestone, Kylee Maclachlan, Anish Simhal, Lucie Broskevicova, Jan Vrana, Ludmila Muronova, Tereza Popkova, Jana Mihalyova, Hana Plonkova, Michael Durante, Bachisio Ziccheddu, Michal Simicek, Hearn Jay Cho, George Mulligan, Jonathan Keats, David Zihala, Ola Landgren, Roman Hajek, Saad Usmani, Francesco Maura, Tomas Jelinek. HemaSphere

Extramedullary disease but not paraskeletal disease portends inferior outcomes after CAR T cell therapy in multiple myeloma. Darren Pan, Tarek H. Mouhieddine, Tianxiang Sheng, Weijia Fu, Erin Moshier, Joshua Richter, Samir Parekh, Sundar Jagannath, Adriana C. Rossi, Larysa J. Sanchez, Santiago Thibaud, Cesar Rodriguez, Hearn J. Cho, Shambavi Richard. Bone Marrow Transplantation

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Cho during 2025 and/or 2026. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Guidepoint

Outside Employment

  • Multiple Myeloma Research Foundation (MMRF)

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.